Hydrochloric Acid → Piperazine, 1-(3,4-dihydroxybenzoyl)-4-methyl-

HRID 1609664Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1609664
[CH3:1][N:2]1[CH2:7][CH2:6][N:5]([C:8](=[O:23])[C:9]2[CH:14]=[CH:13][C:12]([O:15]C(=O)C)=[C:11]([O:19]C(=O)C)[CH:10]=2)[CH2:4][CH2:3]1.C(=O)([O-])[O-].[K+].[K+].Cl>CO>[CH3:1][N:2]1[CH2:7][CH2:6][N:5]([C:8](=[O:23])[C:9]2[CH:14]=[CH:13][C:12]([OH:15])=[C:11]([OH:19])[CH:10]=2)[CH2:4][CH2:3]1

Komponenten

5

Versuchsvorschrift

To a solution of 1-methyl-4-(3,4-diacetoxybenzoyl)piperazine (295 mg) in methanol (3 ml) was added a saturated potassium carbonate solution in methanol (6 ml) and the mixture was stirred at room temperature for 30 minutes. The mixture was poured into ice water and adjusted to pH 9 with 1N hydrochloric acid. The mixture was extracted several times with a mixture of chloroform and methanol (20:1 V/V) and the organic layer was washed with brine, dried over magnesium sulfate and evaporated in vacuo. The residue was crystallized by addition of ethyl acetate to give 1-methyl-4-(3,4-dihydroxybenzoyl)piperazine (71 mg) as white crystal.

Aufarbeitung

  1. extractionThe mixture was extracted several times
  2. additionwith a mixture of chloroform and methanol (20:1 V/V)
  3. washthe organic layer was washed with brine
  4. dry with materialdried over magnesium sulfate
  5. customevaporated in vacuo
  6. customThe residue was crystallized by addition of ethyl acetate

Quellen und Nachweise

ORD-Eintrag
ord-c71945aefda74cf4a217c9017dda1978
Quelldatensatz
uspto-grants-1995_03
Patentnummer
US05401734

Notizen zur Reaktion

Wird geladen…